Biowick X
Payments companies reported to CMS as associated with Biowick X. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Biowick X, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Biowick X
These are the largest totals companies reported as associated with Biowick X. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Mark Frankle | Temple Terrace, FL | Orthopaedic Surgery | $35,128.49 |
| Patrick St Pierre | Rancho Mirage, CA | Orthopaedic Surgery | $24,185.18 |
| Peter Cummings | Phoenix, AZ | Orthopaedic Surgery | $24,185.18 |
| Robert Tashjian | Salt Lake City, UT | Orthopaedic Surgery | $24,185.18 |
| Joseph Abboud | Philadelphia, PA | Orthopaedic Surgery | $24,031.38 |
| Charles Getz | Glen Mills, PA | Orthopaedic Surgery | $23,978.37 |
| Michael Henley | Seattle, WA | Orthopaedic Trauma | $500.00 |
| Bradford Matthews | Ft Wainwright, AK | Orthopaedic Surgery | $325.41 |
| Robert Otte | Bradenton, FL | Orthopaedic Surgery | $174.45 |
| Nirav Amin | Placentia, CA | Orthopaedic Surgery | $161.15 |
Prescribed Biowick X?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.